NFKB1 and obesity disorder: Furthermore, a previous study indicated that inhibition of the NF-κB pathway could relieve HFD-induced obesity and poor glucose intolerance (Benzler et al. 2015), and that Saa1 could activate the NF-κB pathway (Siegmund et al. 2016).